167 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
German language Session
Q&A Modul
SCIENTIFIC PROGRAMME
159
FS-27
Further Session
17:00– 18:30
|
Hall B
TOPIC 28:
History, art and cultural sciences
Schumann: bipolar disorder and the creative
process
Chairs:
Dinesh Bhugra, United Kingdom
Hans-Jürgen Möller, Germany
Speaker:
Richard Kogan, USA
ST-17
State-of-the-Art-Symposium
17:00– 18:30
|
Hall A3
TOPIC 4:
Affective disorders
Persistent and treatment-resistant depressive
disorders
Chairs:
Elisabeth Schramm, Germany
Mazda Adli, Germany
001
Psychotherapy
Elisabeth Schramm, Germany
002
Pharmacotherapy
Mazda Adli, Germany
ST-18 (d)
State-of-the-Art-Symposium
17:00– 18:30
|
Hall A5
TOPIC 3:
Psychotic disorders
Schwierig zu behandelnde Schizophrenie
Chairs:
Stefan Leucht, Germany
Gerhard Gründer, Germany
001
Pharmakologische Behandlung der Schizophrenie:
Darstellung der evidenzbasierten Fakten
Stefan Leucht, Germany
002
Pharmakologische Behandlung der Schizophrenie:
Diskussion praxisrelevanter Fragen
Gerhard Gründer, Germany
S-200
Symposium
17:00– 18:30
|
Hall Helsinki 1
TOPIC 14:
Neurobiology and genetics
Genetics of suicidal behaviour and depression
Chairs:
Dan Rujescu, Germany
Gustavo Turecki, Canada
001
Exome sequencing in treatment resistant de-
pression
Alessandro Serretti, Italy
002
Epigenetic regulation of the suicidal brain
Gustavo Turecki, Canada
003
Molecular insights of dysregulated miRNA
network in locus coeruleus of suicide brain
Yogesh Dwivedi, USA
004
Psychopharmacology of suicide behaviour
Gil Zalsman, Israel
005
Raising the bar in treating suicidal behaviour
Philippe Courtet, France
S-201
Symposium
17:00– 18:30
|
Hall Helsinki 2
TOPIC 18:
Pharmacotherapy
Pharmacogenomics of mood disorders
Chairs:
Bernhard Baune, Australia
Mark Frye, USA
001
Predicting lithium treatment response in bipolar
disorder using RNA-seq data
Oliver Schubert, Australia
002
Pharmacogenomic polygenic risk score analysis
of antidepressant response and antidepressant-in-
duced mania
Mark Frye, USA
003
Pharmacogenomic meta-analysis of antide-
pressant treatment response and side effects: how
to exploit genome-wide data to predict treatment
outcome
Chiara Fabbri, Italy
Gerome Breen, Katherine Tansey, Roy Perlis, Rudolf Uher,
GENDEP Investigators, Joanna Biernacka, Cathryn Lewis
004
Are genetic profile scores of somatic and psy-
chiatric traits predicting antidepressant treatment
response in depression?
Bernhard Baune, Australia
Oliver Schubert, Azmeraw Amare
S-202
Symposium
17:00– 18:30
|
Hall Paris 1
TOPIC 19:
Stimulation methods and interdisciplinary
interventions
Translational research on non-invasive brain stimu-
lation: data from a multisite project
Chairs:
Frank Padberg, Germany
Andre Brunoni, Brazil
001
tDCS in animal models: forward and reverse
translation
Christine Winter, Germany
002
Imaging stimulation: tDCS in health and disease
Daniel Keeser, Germany